These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31992976)

  • 1. Dopamine D
    de Guglielmo G; Kallupi M; Sedighim S; Newman AH; George O
    Front Behav Neurosci; 2019; 13():292. PubMed ID: 31992976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly Developed Dopamine D
    Jordan CJ; Humburg BA; Thorndike EB; Shaik AB; Xi ZX; Baumann MH; Newman AH; Schindler CW
    J Pharmacol Exp Ther; 2019 Dec; 371(3):602-614. PubMed ID: 31562201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The highly selective dopamine D
    Jordan CJ; Humburg B; Rice M; Bi GH; You ZB; Shaik AB; Cao J; Bonifazi A; Gadiano A; Rais R; Slusher B; Newman AH; Xi ZX
    Neuropharmacology; 2019 Nov; 158():107597. PubMed ID: 30974107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D
    You ZB; Bi GH; Galaj E; Kumar V; Cao J; Gadiano A; Rais R; Slusher BS; Gardner EL; Xi ZX; Newman AH
    Neuropsychopharmacology; 2019 Jul; 44(8):1415-1424. PubMed ID: 30555159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats.
    Kimbrough A; Kononoff J; Simpson S; Kallupi M; Sedighim S; Palomino K; Conlisk D; Momper JD; de Guglielmo G; George O
    Psychopharmacology (Berl); 2020 May; 237(5):1545-1555. PubMed ID: 32114633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys.
    Woodlief K; Allen MI; Cornelissen JC; Banks ML; Newman AH; Nader MA
    Neuropsychopharmacology; 2023 Nov; 48(12):1716-1723. PubMed ID: 37118057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats.
    You ZB; Gao JT; Bi GH; He Y; Boateng C; Cao J; Gardner EL; Newman AH; Xi ZX
    Neuropharmacology; 2017 Nov; 126():190-199. PubMed ID: 28888944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain and sex-related behavioral variability of oxycodone dependence in rats.
    Doyle MR; Martinez AR; Qiao R; Dirik S; Di Ottavio F; Pascasio G; Martin-Fardon R; Benner C; George O; Telese F; de Guglielmo G
    Neuropharmacology; 2023 Oct; 237():109635. PubMed ID: 37327971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Negative Allosteric Modulation of M
    Gould RW; Gunter BW; Bubser M; Matthews RT; Teal LB; Ragland MG; Bridges TM; Garrison AT; Winder DG; Lindsley CW; Jones CK
    ACS Chem Neurosci; 2019 Aug; 10(8):3740-3750. PubMed ID: 31268669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nociceptin attenuates the escalation of oxycodone self-administration by normalizing CeA-GABA transmission in highly addicted rats.
    Kallupi M; Carrette LLG; Kononoff J; Solberg Woods LC; Palmer AA; Schweitzer P; George O; de Guglielmo G
    Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2140-2148. PubMed ID: 31932450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic opioid exposure differentially modulates oxycodone self-administration in male and female rats.
    Mavrikaki M; Lintz T; Constantino N; Page S; Chartoff E
    Addict Biol; 2021 May; 26(3):e12973. PubMed ID: 33078503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.
    Matzeu A; Martin-Fardon R
    Neuropharmacology; 2020 Mar; 164():107906. PubMed ID: 31841797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of miR-9 in the Nucleus Accumbens Increases Oxycodone Self-Administration.
    Mavrikaki M; Anastasiadou E; Ozdemir RA; Potter D; Helmholz C; Slack FJ; Chartoff EH
    Int J Neuropsychopharmacol; 2019 Jun; 22(6):383-393. PubMed ID: 30989210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of oxycodone, hydrocodone, and morphine on the responses of D2/D3 dopamine receptors.
    Emery MA; Bates ML; Wellman PJ; Eitan S
    Behav Brain Res; 2015 May; 284():37-41. PubMed ID: 25617530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective M
    Teal LB; Bubser M; Duncan E; Gould RW; Lindsley CW; Jones CK
    Neuropharmacology; 2023 Apr; 227():109424. PubMed ID: 36720403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats.
    Illenberger JM; Flores-Ramirez FJ; Matzeu A; Mason BJ; Martin-Fardon R
    Front Pharmacol; 2023; 14():1127735. PubMed ID: 37180716
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral oxycodone self-administration leads to features of opioid misuse in male and female mice.
    Slivicki RA; Earnest T; Chang YH; Pareta R; Casey E; Li JN; Tooley J; Abiraman K; Vachez YM; Wolf DK; Sackey JT; Kumar Pitchai D; Moore T; Gereau RW; Copits BA; Kravitz AV; Creed MC
    Addict Biol; 2023 Jan; 28(1):e13253. PubMed ID: 36577735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal continuous oral oxycodone self-administration alters pup affective/social communication but not spatial learning or sensory-motor function.
    Zanni G; Robinson-Drummer PA; Dougher AA; Deutsch HM; DeSalle MJ; Teplitsky D; Vemulapalli A; Sullivan RM; Eisch AJ; Barr GA
    Drug Alcohol Depend; 2021 Apr; 221():108628. PubMed ID: 33761428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Adaptations in the Rat Dorsal Striatum and Hippocampus Following Abstinence-Induced Incubation of Drug Seeking After Escalated Oxycodone Self-Administration.
    Blackwood CA; Hoerle R; Leary M; Schroeder J; Job MO; McCoy MT; Ladenheim B; Jayanthi S; Cadet JL
    Mol Neurobiol; 2019 May; 56(5):3603-3615. PubMed ID: 30155791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective D3-Receptor antagonist VK4-116 effectively treats behavioral inflexibility in rats caused by self-administration and withdrawal from cocaine.
    Panayi MC; Shetty S; Porod M; Bahena L; Xi ZX; Newman AH; Schoenbaum G
    bioRxiv; 2023 Sep; ():. PubMed ID: 37732238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.